BRPI1009971A2 - método de redução da pressão intraocular em humanos - Google Patents

método de redução da pressão intraocular em humanos

Info

Publication number: BRPI1009971A2
Authority: BR; Brazil
Prior art keywords: humans; intraocular pressure; reducing intraocular; reducing; pressure
Prior art date: 2009-05-01

Application number

BRPI1009971A

Other languages

English (en)

Inventor

Rudolf A Baumgartner

Shikha Barman

Original Assignee

Inoteck Pharmaceuticals Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-01

Filing date

2010-04-30

Publication date

2016-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43030847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1009971(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-04-30 Application filed by Inoteck Pharmaceuticals Corp filed Critical Inoteck Pharmaceuticals Corp

2016-03-15 Publication of BRPI1009971A2 publication Critical patent/BRPI1009971A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Ophthalmology & Optometry (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Prostheses (AREA)

BRPI1009971A 2009-05-01 2010-04-30 método de redução da pressão intraocular em humanos BRPI1009971A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17465509P	2009-05-01	2009-05-01
US21999009P	2009-06-24	2009-06-24
PCT/US2010/033112 WO2010127210A1 (en)	2009-05-01	2010-04-30	Method of reducing intraocular pressure in humans

Publications (1)

Publication Number	Publication Date
BRPI1009971A2 true BRPI1009971A2 (pt)	2016-03-15

Family

ID=43030847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1009971A BRPI1009971A2 (pt)	2009-05-01	2010-04-30	método de redução da pressão intraocular em humanos

Country Status (25)

Country	Link
US (2)	US8470800B2 (pt)
EP (1)	EP2424546B1 (pt)
JP (1)	JP5778663B2 (pt)
KR (1)	KR101757940B1 (pt)
CN (1)	CN102413832B (pt)
AU (1)	AU2010242943B2 (pt)
BR (1)	BRPI1009971A2 (pt)
CA (1)	CA2762064A1 (pt)
CL (1)	CL2011002675A1 (pt)
DK (1)	DK2424546T3 (pt)
EA (1)	EA024042B1 (pt)
ES (1)	ES2554684T3 (pt)
HR (1)	HRP20151200T1 (pt)
HU (1)	HUE028068T2 (pt)
IL (1)	IL216081A (pt)
MX (1)	MX2011011229A (pt)
MY (1)	MY159244A (pt)
NZ (1)	NZ596428A (pt)
PL (1)	PL2424546T3 (pt)
PT (1)	PT2424546E (pt)
RS (1)	RS54378B1 (pt)
SG (1)	SG175346A1 (pt)
SI (1)	SI2424546T1 (pt)
SM (1)	SMT201500295B (pt)
WO (1)	WO2010127210A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102008062567A1 (de)	2008-12-16	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) *	2009-01-29	2010-08-05	Bayer Schering Pharma Aktiengesellschaft	Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
MX2012004225A (es) *	2009-10-26	2012-06-08	Inotek Pharmaceuticals Corp	Formulacion oftalmica y metodo de fabricacion de la misma.
ME02608B (me) *	2010-01-11	2017-06-20	Inotek Pharmaceuticals Corp	Kombinacija, komplet i postupak snižavanja intraokularnog pritiska
PT2555776T (pt) *	2010-03-19	2017-02-01	Inotek Pharmaceuticals Corp	Composições de combinação de agonistas de adenosina a1 e bloqueadores não selectivos dos receptores adrenérgicos beta para redução da pressão intra-ocular
HUE031529T2 (en) *	2010-03-19	2017-07-28	Inotek Pharmaceuticals Corp	Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing intraocular pressure
AU2011230580A1 (en) *	2010-03-26	2012-10-11	Inotek Pharmaceuticals Corporation	Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
DE102010030688A1 (de)	2010-06-30	2012-01-05	Bayer Schering Pharma Aktiengesellschaft	Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en) *	2010-09-02	2012-03-08	Bayer Pharma Aktiengesellschaft	Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
SG10201701343QA (en) *	2012-01-26	2017-04-27	Inotek Pharmaceuticals Corp	Anhydrous Polymorphs of (2r,3s,4r,5r)-5-(6-(Cyclopentylamino)-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydrofuran-2-Yl) } Methyl Nitrate and Processes of Preparation Thereof
CN105188714A (zh)	2013-03-15	2015-12-23	伊诺泰克制药公司	眼用配制品
BR112017011891A2 (pt) *	2014-12-03	2018-07-03	Inotek Pharmaceuticals Corp	métodos de prevenção, redução ou tratamento de degeneração macular

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101010085B (zh)	2004-05-26	2012-12-26	伊诺泰克制药公司	嘌呤衍生物作为腺苷a1受体激动剂及其用法
CA2567289C (en) *	2004-05-26	2013-12-31	Inotek Pharmaceuticals Corporation	Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
EA015683B1 (ru) *	2005-11-30	2011-10-31	Инотек Фармасьютикалз Корпорейшн	Производные пурина и способы их применения
MX2012004225A (es) *	2009-10-26	2012-06-08	Inotek Pharmaceuticals Corp	Formulacion oftalmica y metodo de fabricacion de la misma.
ME02608B (me) *	2010-01-11	2017-06-20	Inotek Pharmaceuticals Corp	Kombinacija, komplet i postupak snižavanja intraokularnog pritiska
PT2555776T (pt) *	2010-03-19	2017-02-01	Inotek Pharmaceuticals Corp	Composições de combinação de agonistas de adenosina a1 e bloqueadores não selectivos dos receptores adrenérgicos beta para redução da pressão intra-ocular
HUE031529T2 (en) *	2010-03-19	2017-07-28	Inotek Pharmaceuticals Corp	Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing intraocular pressure

2010
- 2010-04-30 CA CA2762064A patent/CA2762064A1/en not_active Abandoned
- 2010-04-30 MY MYPI2011004858A patent/MY159244A/en unknown
- 2010-04-30 AU AU2010242943A patent/AU2010242943B2/en not_active Ceased
- 2010-04-30 EP EP10770402.5A patent/EP2424546B1/en active Active
- 2010-04-30 SG SG2011078151A patent/SG175346A1/en unknown
- 2010-04-30 WO PCT/US2010/033112 patent/WO2010127210A1/en active Application Filing
- 2010-04-30 SI SI201031070T patent/SI2424546T1/sl unknown
- 2010-04-30 ES ES10770402.5T patent/ES2554684T3/es active Active
- 2010-04-30 PT PT107704025T patent/PT2424546E/pt unknown
- 2010-04-30 KR KR1020117025057A patent/KR101757940B1/ko active Active
- 2010-04-30 BR BRPI1009971A patent/BRPI1009971A2/pt not_active IP Right Cessation
- 2010-04-30 MX MX2011011229A patent/MX2011011229A/es unknown
- 2010-04-30 HU HUE10770402A patent/HUE028068T2/en unknown
- 2010-04-30 NZ NZ596428A patent/NZ596428A/en not_active IP Right Cessation
- 2010-04-30 DK DK10770402.5T patent/DK2424546T3/en active
- 2010-04-30 RS RS20150782A patent/RS54378B1/en unknown
- 2010-04-30 US US12/771,289 patent/US8470800B2/en not_active Expired - Fee Related
- 2010-04-30 PL PL10770402T patent/PL2424546T3/pl unknown
- 2010-04-30 JP JP2012508764A patent/JP5778663B2/ja not_active Expired - Fee Related
- 2010-04-30 EA EA201171339A patent/EA024042B1/ru not_active IP Right Cessation
- 2010-04-30 CN CN201080018539.XA patent/CN102413832B/zh not_active Expired - Fee Related
2011
- 2011-10-27 CL CL2011002675A patent/CL2011002675A1/es unknown
- 2011-11-01 IL IL216081A patent/IL216081A/en not_active IP Right Cessation
2013
- 2013-04-03 US US13/855,919 patent/US20130217643A1/en not_active Abandoned
2015
- 2015-11-09 HR HRP20151200TT patent/HRP20151200T1/hr unknown
- 2015-11-30 SM SM201500295T patent/SMT201500295B/it unknown

Also Published As

Publication number	Publication date
JP2012525437A (ja)	2012-10-22
NZ596428A (en)	2014-03-28
AU2010242943A1 (en)	2011-12-01
EP2424546B1 (en)	2015-10-28
US20130217643A1 (en)	2013-08-22
KR20120017026A (ko)	2012-02-27
IL216081A0 (en)	2012-01-31
SI2424546T1 (sl)	2016-02-29
MX2011011229A (es)	2011-11-18
RS54378B1 (en)	2016-04-28
HRP20151200T1 (hr)	2016-01-15
CA2762064A1 (en)	2010-11-04
EP2424546A4 (en)	2013-01-23
EA024042B1 (ru)	2016-08-31
US20100279970A1 (en)	2010-11-04
SMT201500295B (it)	2016-01-08
CN102413832B (zh)	2015-11-25
AU2010242943B2 (en)	2016-09-29
HK1167599A1 (en)	2012-12-07
CN102413832A (zh)	2012-04-11
WO2010127210A1 (en)	2010-11-04
CL2011002675A1 (es)	2012-06-01
US8470800B2 (en)	2013-06-25
PL2424546T3 (pl)	2016-04-29
EP2424546A1 (en)	2012-03-07
MY159244A (en)	2016-12-30
IL216081A (en)	2015-11-30
JP5778663B2 (ja)	2015-09-16
SG175346A1 (en)	2011-11-28
PT2424546E (pt)	2015-12-23
KR101757940B1 (ko)	2017-07-13
DK2424546T3 (en)	2015-12-14
EA201171339A1 (ru)	2012-05-30
HUE028068T2 (en)	2016-11-28
ES2554684T3 (es)	2015-12-22

Publication	Publication Date	Title
BRPI1009971A2 (pt)	2016-03-15	método de redução da pressão intraocular em humanos
BR112012013954A2 (pt)	2016-06-07	derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico e método de modificação do derivado de ácido hialurônico
BRPI1006537A2 (pt)	2017-05-02	método e artigo
BRPI0920498A2 (pt)	2019-09-24	método de tratamento de uma condição em um sujeito
BR112012004707A2 (pt)	2016-04-12	método
BR112012000624A2 (pt)	2016-02-10	método
FI20090389A0 (fi)	2009-10-23	Menetelmä
PL2490940T3 (pl)	2021-12-13	System i metoda bsp
BR112012001172A2 (pt)	2017-01-31	artigo, e, método
BRPI1011198A2 (pt)	2016-03-15	trajes de compressão e método de fabricação
BR112012010369A2 (pt)	2019-09-24	peça de vestuário e método de produção da mesma
PL2308325T3 (pl)	2013-02-28	Sposób wysokociśnieniowej obróbki produktów
BRPI1006563A2 (pt)	2018-02-14	método de dobragem de artigo absorvente
EP2496176A4 (en)	2013-10-23	ENTZELLULARISIERUNGSVERFAHREN
LT3156075T (lt)	2021-01-11	Oligosacharidas ir jo paruošimo būdas
BRPI1012526A2 (pt)	2016-03-29	método
BRPI0924559A2 (pt)	2019-09-24	estrutura de aeronave, aeronave e método de fabricação da dita estrutura de aeronave
BRPI1010705A2 (pt)	2015-09-15	método
EP2424476A4 (en)	2012-11-21	RETINA GRAFT
GB201120167D0 (en)	2012-01-04	Flow-actuated actuator and method
EP2517572A4 (en)	2012-12-05	INSTANT NOODLES AND METHOD FOR MANUFACTURING THE SAME
BRPI1012532A2 (pt)	2016-03-29	método
FI20090357L (fi)	2011-03-29	Menetelmä ja järjestely
SMT201700017B (it)	2017-03-08	Combinazione, kit e metodo per ridurre la pressione intraoculare
PT2519505E (pt)	2015-09-03	Derivados de 8-hidroxiquinolina-7-carboxamida terciários e suas utilizações

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-10	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-15	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-12-26	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-02-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 9A ANUIDADE.
2019-06-25	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2512 DE 26-02-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.